A calcium-sensitive antibody isolates soluble amyloid-β aggregates and fibrils from Alzheimer's disease brain.
A calcium-sensitive antibody isolates soluble amyloid-β aggregates and fibrils from Alzheimer's disease brain.
复制标题
DOI:
10.1093/brain/awac023
复制
发表时间:
2022-07-29
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Aqueously soluble oligomers of amyloid-β peptide may be the principal neurotoxic forms of amyloid-β in Alzheimer’s disease, initiating downstream events that include tau hyperphosphorylation, neuritic/synaptic injury, microgliosis and neuron loss. Synthetic oligomeric amyloid-β has been studied extensively, but little is known about the biochemistry of natural oligomeric amyloid-β in human brain, even though it is more potent than simple synthetic peptides and comprises truncated and modified amyloid-β monomers. We hypothesized that monoclonal antibodies specific to neurotoxic oligomeric amyloid-β could be used to isolate it for further study. Here we report a unique human monoclonal antibody (B24) raised against synthetic oligomeric amyloid-β that potently prevents Alzheimer’s disease brain oligomeric amyloid-β-induced impairment of hippocampal long-term potentiation. B24 binds natural and synthetic oligomeric amyloid-β and a subset of amyloid plaques, but only in the presence of Ca2+. The amyloid-β N terminus is required for B24 binding. Hydroxyapatite chromatography revealed that natural oligomeric amyloid-β is highly avid for Ca2+. We took advantage of the reversible Ca2+-dependence of B24 binding to perform non-denaturing immunoaffinity isolation of oligomeric amyloid-β from Alzheimer’s disease brain-soluble extracts. Unexpectedly, the immunopurified material contained amyloid fibrils visualized by electron microscopy and amenable to further structural characterization. B24-purified human oligomeric amyloid-β inhibited mouse hippocampal long-term potentiation. These findings identify a calcium-dependent method for purifying bioactive brain oligomeric amyloid-β, at least some of which appears fibrillar. Stern et al. develop a new monoclonal antibody specific to neurotoxic oligomers of amyloid-beta peptide. A unique calcium-sensitive property of this antibody enables isolation of soluble amyloid-beta aggregates from Alzheimer’s disease brain without denaturation, some of which exhibit fibrillar morphology.
登录
查看更多内容
DOI:
10.1186/s13195-021-00813-8
发表时间:
2021-04-17
期刊:
Alzheimer's research & therapy
影响因子:
--
作者:
Swanson CJ;Zhang Y;Dhadda S;Wang J;Kaplow J;Lai RYK;Lannfelt L;Bradley H;Rabe M;Koyama A;Reyderman L;Berry DA;Berry S;Gordon R;Kramer LD;Cummings JL
通讯作者:
Cummings JL
DOI:
10.1126/science.aao2825
发表时间:
2017-10-06
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Gremer L;Schölzel D;Schenk C;Reinartz E;Labahn J;Ravelli RBG;Tusche M;Lopez-Iglesias C;Hoyer W;Heise H;Willbold D;Schröder GF
通讯作者:
Schröder GF
影响因子:
64.8
作者:
Qiang W;Yau WM;Lu JX;Collinge J;Tycko R
通讯作者:
Tycko R
DOI:
10.1523/jneurosci.0203-11.2011
发表时间:
2011-05-04
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Li S;Jin M;Koeglsperger T;Shepardson NE;Shankar GM;Selkoe DJ
通讯作者:
Selkoe DJ
影响因子:
25
作者:
Nilsberth, C;Westlind-Danielsson, A;Lannfelt, L
通讯作者:
Lannfelt, L